In a recent study, Short-course neoadjuvant in situ vaccination for murine melanoma, researchers compared the effectiveness of neoadjuvant radiotherapy and/or tumor vaccination. See more below and the full study here.
Xstrahl to Feature New MuriSuite and Voxl at RadRes 2025 in San Juan, PR
Xstrahl, the leader in preclinical radiation research systems, will demonstrate SmART-RAD at the 70th Annual Meeting of the Radiation Research Society (RRS) at the Westin La Paloma Resort & Spa, in Tucson, AZ, Sept. 15-18.